Trialect

Active

Inflammatory Bowel Disease, Colorectal Cancer Prevention and Autoimmune Liver Disorders

McGovern Medical School at The University of Texas Health Science Center

Dr. Tugrul Purnak, is an Associate Professor in the Division of Gastroenterology, Hepatology, and Nutrition at McGovern Medical School. He is a board-certified gastroenterologist with specialized expertise in transplant hepatology and advanced endoscopy.

His clinical focus includes the management of complex liver diseases, particularly autoimmune hepatitis, biliary disorders, inflammatory bowel diseases and cirrhosis. Dr. Purnak’s research interests center on the diagnosis and medical management of liver diseases, inflammatory bowel diseases with contributions to international collaborations and gastroenterology societies.

Dr. Tugrul Purnak is a faculty member at McGovern Medical School. He conducts this training program in his personal capacity and not as a representative of, or on behalf of, McGovern Medical School.

Programs will be conducted during the following periods: May–June; September–October; February–March.

Main Areas of Interest

Inflammatory bowel disease (Crohn’s disease and ulcerative colitis)
Advanced therapeutics in IBD (biologics, immunomodulators, small molecules)
Colorectal cancer prevention and inflammation-associated carcinogenesis
Autoimmune liver diseases and hepatology

Specialties

Hepatology

Gastroenterology

Hepatobiliary Surgery

Gastrointestinal Surgery

Techniques You Will Learn

Endoscopic evaluation and mucosal disease assessment (colonoscopy, surveillance strategies)
Clinical decision-making in IBD (treatment algorithms, biologic selection, monitoring response)
Interpretation of histopathology and biomarkers in GI and liver diseases
Management of autoimmune liver diseases (diagnostic workup, immunosuppressive therapy)
Proposed Fellowship Title

Modules

Foundations of Inflammatory Bowel Disease

Pathophysiology of Crohn’s disease and ulcerative colitis
Disease classification and severity assessment
Clinical presentation and diagnostic criteria

Advanced Therapeutics in IBD

Biologic therapies (anti-TNF, integrin inhibitors, IL inhibitors)
Small molecules (JAK inhibitors, S1P modulators)
Personalized and treat-to-target strategies

Endoscopic and Surveillance Strategies

Colonoscopic evaluation in IBD
Dysplasia detection and surveillance protocols
Early detection and prevention of colorectal cancer

Autoimmune Liver Diseases in GI Practice

Autoimmune hepatitis, PBC, PSC: diagnosis and management
Overlap syndromes and systemic autoimmune associations
Integration of hepatology in GI care

Program Fee


Total Number of Modules	5
Total Program Cost	$650.00

Who Can Apply

Residents in Internal Medicine seeking subspecialty exposure in advanced GI care
Fellows in Gastroenterology/Hepatology aiming to deepen expertise in Inflammatory Bowel Disease and liver diseases
Early-career physicians interested in advanced therapeutics, endoscopy, and multidisciplinary GI care
PhD candidates and clinical researchers focusing on translational research in GI diseases and Colorectal Cancer
International medical graduates (IMGs) seeking structured academic exposure to IBD, hepatology, and clinical research

Host Details

Host Name: Dr. Tugrul Purnak, MD

Affiliation: McGovern Medical School at The University of Texas Health Science Center

Address: McGovern Medical School at The University of Texas Health Science Center at Houston 6431 Fannin Houston, TX 77030

Website URL:

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.